Skip to main content
logo
bioXXmed AG (FRA:T5O)
Germany flag Germany · Delayed Price · Currency is EUR
1.020
+0.020 (2.00%)
Last updated: Oct 6, 2026, 7:36 PM CET

bioXXmed AG Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
0015618
Market Cap Growth
70.00%-95.56%-86.90%-9.91%-69.02%-70.98%
Enterprise Value
0014218
Last Close Price
1.020.116.5541.0145.52185.86

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-14.7214.7214.7214.7214.72
PS Ratio
-1030.861.79192.67295.19466.16412.49
PB Ratio
--29905.002.1110.930.271.03
P/TBV Ratio
--2.1110.930.271.03

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-5.25167.63233.04165.61394.46

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
--385000.00-0.02-0.01
Net Debt / Equity Ratio
--181332.00-0.80-1.29-0.090.01
Net Debt / EBITDA Ratio
-1.31-0.670.290.752.25-0.08
Net Debt / FCF Ratio
--0.540.280.832.01-
Asset Turnover
-0.040.010.000.000.00
Quick Ratio
92.67234.643.156.6013.830.16
Current Ratio
151.33356.124.047.3614.230.38
Return on Equity (ROE)
-585.37%-229.36%-252.84%-191.41%-4.23%-20.40%
Return on Assets (ROA)
-14.04%-35.44%-93.01%-4.52%-2.58%-4.84%
Return on Capital Employed (ROCE)
-18.90%-57.90%-214.30%-136.40%-3.80%-8.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-66.49%-1221.84%-148.13%-407.77%-14.55%-22.05%
FCF Yield
--1120.21%-136.11%-14.21%-16.03%-
Buyback Yield / Dilution
-0.00%-164.59%--27.54%-